This report contains market size and forecasts of Renal Anemia Therapeutics in Global, including the following market information:
Global Renal Anemia Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Renal Anemia Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
DS-1093 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Renal Anemia Therapeutics include Bayer AG, BIOCAD, CCM Duopharma Biotech Bhd., Chong Kun Dang Pharmaceutical Corp., Daiichi Sankyo Company, Limited, Dong-A Socio Group, Dr. Reddy's Laboratories Limited, Eli Lilly and Company and FibroGen, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Renal Anemia Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Renal Anemia Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Renal Anemia Therapeutics Market Segment Percentages, by Type, 2021 (%)
DS-1093
EPO-018B
FG-2216
JTZ-951
MDGN-201
MMP-0101
Others
Global Renal Anemia Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Renal Anemia Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital
Research Center
Clinic
Global Renal Anemia Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Renal Anemia Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Renal Anemia Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Renal Anemia Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
BIOCAD
CCM Duopharma Biotech Bhd.
Chong Kun Dang Pharmaceutical Corp.
Daiichi Sankyo Company, Limited
Dong-A Socio Group
Dr. Reddy's Laboratories Limited
Eli Lilly and Company
FibroGen, Inc.
GlaxoSmithKline Plc
Intas Pharmaceuticals Ltd.
Japan Tobacco Inc.
JCR Pharmaceuticals Co., Ltd.
Jiangsu Hansoh Pharmaceutical Co., Ltd.